Nine Chapters Capital Management’s Bio-Techne TECH Stock Holding History

Nine Chapters Capital Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-18,000	Closed	-$416K	–	1126
2014 Q4	$416K	Sell	18,000 -63,200	-78%	-$1.45M	0.04%	589
2014 Q3	$1.9M	Sell	81,200 -4,400	-5%	-$103K	0.17%	168
2014 Q2	$1.98M	Buy	85,600 +42,800	+100%	+$946K	0.16%	177
2014 Q1	$913K	Buy	42,800 +10,800	+34%	+$243K	0.11%	283
2013 Q4	$757K	Buy	32,000 +3,200	+11%	+$69.4K	0.08%	357
2013 Q3	$576K	Buy	+28,800	New	+$546K	0.07%	385

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nine Chapters Capital Management's TECH Position: Q1 2015 in Review

Nine Chapters Capital Management sold out of Bio-Techne (TECH) in Q1 2015, closing a stake of 18,000 shares — an estimated $416K sold.

Nine Chapters Capital Management first reported a position in TECH in Q3 2013 and held it in 6 quarters. The position peaked at $1.98M in Q2 2014. 252 funds tracked by Wall St. Rank hold TECH as of Q1 2015.

Nine Chapters Capital Management reported no remaining Bio-Techne position as of Q1 2015 after selling out during the quarter.
Nine Chapters Capital Management sold 18,000 Bio-Techne shares in Q1 2015, an estimated $416K.
Nine Chapters Capital Management first reported a position in Bio-Techne in Q3 2013 and held it in 6 quarters.
Nine Chapters Capital Management's Bio-Techne position peaked at $1.98M in Q2 2014.
252 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2015.

Based on Nine Chapters Capital Management's 13F filing for Q1 2015, filed 15 May 2015.